Researchers explore immune responses to mpox infections
Can't see this email? View it online
   
  Mpox  
  The latest Mpox news from News Medical  
 Discovery of a potential new target for new MPOX or broad pox vaccinesDiscovery of a potential new target for new MPOX or broad pox vaccines
 
In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom developed a pooled enzyme-linked immunosorbent (ELISA) assay using mpox (MPX) virus (MPXV) antigens and vaccinia virus (VACV) antigens. They also assessed humoral responses to and identification of antigens of MPXV IIa clade and IIb clade, in comparison to recipients of smallpox vaccines (ACAM2000 and IMVANEX).
 
 
 Researchers explore immune responses to mpox infectionsResearchers explore immune responses to mpox infections
 
In new research, researchers demonstrated that individuals recovering from mpox virus (MPXV) infection have neutralizing antibodies that target MPXV antigens A35R and H3L.
 
   The main source of editing of the mpox virus genome during the 2022 outbreakThe main source of editing of the mpox virus genome during the 2022 outbreak
 
Researchers investigated the main source of editing of the 2022 mpox virus genome.
 
 Clinical and genomic signatures of monkeypox outbreaks in 2022
 
Clinical and genomic signatures of monkeypox outbreaks in 2022Announcing a new article publication for Zoonoses journal. The monkeypox outbreaks started in 2022 and became an unexpected public health emergency of international concern (PHEIC).
 
 
 Exploring a novel amplicon-based mpox virus sequencing strategy
 
Exploring a novel amplicon-based mpox virus sequencing strategyResearchers described the development of a sequencing strategy based on amplicons for mpox detection.